TradingMarkets’ 7 Stocks You Need To Know About Today
OSI Pharmaceuticals
(
OSIP |
Quote |
Chart |
News |
PowerRating) said the FDA has accepted a New Drug
application for Tarceva plus gemcitabine chemotherapy for pancreatic cancer
treatment. In additions, Tarceva was granted priority review classification.
Zion’s Bancorp will acquire Amegy for $1.7 billion.
UBS raised June estimates on Intel
(
INTC |
Quote |
Chart |
News |
PowerRating), to 0.33 from 0.32.
JP Morgan raised estimates on Motorola
(
MOT |
Quote |
Chart |
News |
PowerRating).
Marvel Enterprises
(
MVL |
Quote |
Chart |
News |
PowerRating) was downgraded to neutral at JP Morgan.
Zoll Medical
(
ZOLL |
Quote |
Chart |
News |
PowerRating) warned for Q3; the company now expects
breakeven vs 0.10.